All News #Library
Biotech
Georgiamune Appoints Mark Avagliano As Chief Business Officer
19 Nov 2024 //
GLOBENEWSWIRE
Georgiamune Doses First Participant in GIM-407 Phase 1 Trial
24 Sep 2024 //
GLOBENEWSWIRE
Georgiamune Doses First Patient In Phase 1 GIM-531 Cancer Trial
30 Jul 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support